Human herpesvirus 8 glycoprotein K8.1: Expression, post-translational modification and localization analyzed by monoclonal antibody

Journal of Clinical Virology

Volumn 17, Issue 2, 2000, Pages 127-136

  Wu, Lijun ^a   Renne, Rolf ^b   Ganem, Don ^c   Forghani, Bagher ^a  

^a VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glycoprotein; Human herpesvirus 8 (HHV 8); K8.1; Monoclonal antibody

Indexed keywords

COMPLEMENTARY DNA; GLUCOSAMINE; GLYCOPEPTIDASE; GLYCOSIDASE; MONOCLONAL ANTIBODY; N ACETYL BETA GLUCOSAMINIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; CROSS REACTION; DEGLYCOSYLATION; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; SEQUENCE ANALYSIS; VIRAL GENETICS; VIRION;

ALTERNATIVE SPLICING; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BACULOVIRIDAE; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; GLYCOPROTEINS; GLYCOSIDE HYDROLASES; GLYCOSYLATION; HERPESVIRUS 8, HUMAN; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR WEIGHT; OPEN READING FRAMES; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, VIRAL; SPODOPTERA; TETRADECANOYLPHORBOL ACETATE; VIRAL PROTEINS; VIRION;

EID: 0033837397     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(00)00085-8     Document Type: Article

References (32)

1. Albrecht J.C., Nicholas J., Biller D. et al. Primary structure of the herpesvirus saimiri genome. J. Virol. 66:1992;5047-5058.
2. Beisel C., Tanner J., Matsuo T., Thorley-Lawson D., Kezdy F., Kieff E. Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene. J. Virol. 54:1985;6657-6674.
3. Cesarman E., Chang Y., Moore P.S., Said J.W., Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New Engl. J. Med. 332:1995;1186-1191.
4. Chandran B., Bloomer C., Chan S.R., Zhu L., Goldstein E., Horvat R. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoprotems generated by spliced transcripts. Virology. 249:1998;140-149.
5. Chandran B., Smith M.S., Koelle D.M., Corey L., Horvat R., Goldstein E. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology. 243:1998;208-217.
6. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
7. Forghani B., Schmidt N.J. Humoral immune response to virions and dense bodies of human cytomegalovirus determined by enzyme immunoassay. J. Med. Virol. 6:1980;119-127.
8. Forghani B., Dupuis K.W., Schmidt N.J. Varicella-zoster viral glycoproteins analyzed by monoclonal antibodies. J. Virol. 52:1984;55-62.
9. Forghani B., Karu A.E. Monoclonal antibodies. Harper D.R. Virology. 1993;187-214 Bios Scientific, Oxford.
10. Hummel M., Thorley-Lawson D., Kieff E. An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200). J. Virol. 49:1984;413-417.
11. Iatrou K., Meidinger R.G., Goldsmith M.R. Recombinant baculoviruses as vectors for identifying proteins encoded by intron-containing members of complex multigene families. Proc. Natl. Acad. Sci. USA. 86:1989;9129-9133.
12. Ishii K., Yamagami S., Tanaka H., Motoki M., Suwa Y., Endo N. Full active baculovirus-expressed human monocyte chemoattractant protein 1 with the intact N-terminus. Biochem. Biophys. Res. Commun. 206:1995;955-961.
13. Jeang K.T., Holmgren-Konig M., Khoury G. A baculovirus vector can express intron-containing genes. J. Virol. 61:1987;1761-1764.
14. Khyatti M., Patel P.C., Stefanescu I., Menezes J. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity. J. Virol. 65:1991;996-1001.
15. Li M., MacKey J., Czajak S.C., Desrosiers R.C., Lackner A.A., Jung J.U. Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein. J. Virol. 73:1999;1341-1349.
16. Martin J.N., Amad Z., Cossen C. et al. Use of epidemiologically well-defined subjects and existing immunofluoresence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J. Clin. Microbiol. 38:2000;696-701.
17. Moore P.S., Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. New Engl. J. Med. 332:1995;1181-1185.
18. Moore P.S., Gao S.J., Dominguez G. et al. Primary characterization of a heipesvirus agent associated with Kaposi's sarcomae. J. Virol. 70:1996;548-558.
19. Neipel F., Albrecht J.C., Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity. J. Virol. 71:1997;A187-192.
20. Nemerow G.R., Houghten R.A., Moore M.D., Cooper N.R. Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell. 56:1989;369-377.
21. Nemerow G.R., Mold C., Schwend V.K., Tollefson V., Cooper N.R. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EbV/C3d receptor of B-cells: sequence homology of gp350 and C3 complement fragment C3d. J. Virol. 61:1987;1416-1420.
22. Raab M.S., Albrecht J.C., Birkmann A. et al. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J. Virol. 72:1998;6725-6731.
23. Renne R., Lagunoff M., Zhong W., Ganem D. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpes virus 8) DNA in infected cells and virions. J. Virol. 70:1996;8151-8154.
24. Renne R., Zhong W., Herndier B. et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:1996;342-346.
25. Russo J.J., Bohenzky R.A., Chien M.C. et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:1996;14862-14867.
26. Sadler R., Wu L., Forghani B. et al. A complex translational program generates multiple novel proteins from the latently expressed koposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73:1999;5722-5730.
27. Soulier J., Grollet L., Oksenhendler E. et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 86:1995;1276-1280.
28. Tanner J., Weis J., Fearon D., Whang Y., Kieff E. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell. 50:1987;203-213.
29. Thorley-Lawson D.A., Geilinger K. Monoclonal antibodies against the major (gp320/gp220) of Epstein-Barr virus neutralize infectivity. Proc. Natl. Acad. Sci. USA. 77:1980;5307-5311.
30. Wu L., Forghani B. Characterization of neutralizing domains on varicella-zoster virus glycoprotein E defined by monoclonal antibodies. Arch. Virol. 142:1997;349-362.
31. Zoeteweij J.P., Eyes S.T., Orenstein M. et al. Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents. J. Virol. 73:1999;5894-5901.
32. Zhu L., Wang R., Sweat A. et al. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology. 256:1999;381-392.